MYC and liver cancer: Our results showed that miR-34a inhibited luciferase activity significantly, whereas no effect was observed when their respective target sites were mutated, suggesting that miR-34a directly targets c-Myc and FoxM1 via binding to the 3′ UTRs in liver cancer cells (Figure 4D, 4G).